FLT3-ITD急性髓系白血病中细胞质DROSHA与miR-155非经典生成机制
本研究揭示FLT3-ITD通过磷酸化SPRED1抑制XPO5/RAN-GTP复合物,阻断经典miRNA生成;但miR-155仍上调,机制为FLT3-ITD经p-AKT抑制DDX3X,使未剪接BIC-155经NXF1出核,由细胞质DROSHA加工为成熟miR-155。
要点
- FLT3-ITD磷酸化SPRED1抑制XPO5/RAN-GTP,阻断经典miRNA出核成熟。
- FLT3-ITD经p-AKT抑制DDX3X,增加未剪接BIC-155。
- 未剪接BIC-155经NXF1出核,由细胞质DROSHA加工为成熟miR-155。
核心结论
- FLT3-ITD通过非经典机制上调miR-155,促进AML原始细胞增殖。
研究设计与样本
- 基于FLT3-ITD+ AML原始细胞的分子机制研究,未报告样本量。
主要发现
- FLT3-ITD磷酸化SPRED1,抑制XPO5/RAN-GTP复合物,阻断经典miRNA生成。
- FLT3-ITD经p-AKT抑制DDX3X,增加未剪接BIC-155。
- 未剪接BIC-155经NXF1出核,由细胞质DROSHA加工为成熟miR-155。
临床怎么用
- 提示FLT3-ITD+ AML中miR-155上调不依赖经典出核通路,或可探索靶向非经典生成环节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We report here on a novel pro-leukemogenic role of FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) that interferes with microRNAs (miRNAs) biogenesis in acute myeloid leukemia (AML) blasts. We showed that FLT3-ITD interferes with the canonical biogenesis of intron-hosted miRNAs such as miR-126, by phosphorylating SPRED1 protein and inhibiting the "gatekeeper" Exportin 5 (XPO5)/RAN-GTP complex that regulates the nucleus-to-cytoplasm transport of pre-miRNAs for completion of maturation into mature miRNAs. Of note, despite the blockage of "canonical" miRNA biogenesis, miR-155 remains upregulated in FLT3-ITD+ AML blasts, suggesting activation of alternative mechanisms of miRNA biogenesis that circumvent the XPO5/RAN-GTP blockage. MiR-155, a BIC-155 long noncoding (lnc) RNA-hosted oncogenic miRNA, has previously been implicated in FLT3-ITD+ AML blast hyperproliferation. We showed that FLT3-ITD upregulates miR-155 by inhibiting DDX3X, a protein implicated in the splicing of lncRNAs, via p-AKT. Inhibition of DDX3X increases unspliced BIC-155 that is then shuttled by NXF1 from the nucleus to the cytoplasm, where it is processed into mature miR-155 by cytoplasmic DROSHA, thereby bypassing the XPO5/RAN-GTP blockage via "non-canonical" mechanisms of miRNA biogenesis.
引用
- Nguyen LXT, Zhang B, Hoang DH, et al. Cytoplasmic DROSHA and non-canonical mechanisms of MiR-155 biogenesis in FLT3-ITD acute myeloid leukemia. Leukemia. 2021. PMID: 33589748. doi:10.1038/s41375-021-01166-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。